Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites.
作者信息
Kalambokis Georgios N, Tsianos Epameinondas V
机构信息
Lecturer, 1 Division of Internal Medicine and Hepato-Gastroenterology Unit, Medical School of Ioannina, Ioannina, Greece.
出版信息
J Res Med Sci. 2011 Dec;16(12):1636-7.
Abstract
摘要
相似文献
1
Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites.米多君和奥曲肽对肝硬化腹水患者的全身血流动力学及肾脏的影响
J Res Med Sci. 2011 Dec;16(12):1636-7.
2
The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.奥曲肽与奥曲肽联合米多君长期治疗对非氮质血症性肝硬化腹水患者全身血流动力学、肾血流动力学及肾功能的影响。
Am J Gastroenterol. 2005 Apr;100(4):879-85. doi: 10.1111/j.1572-0241.2005.40899.x.
3
Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.米多君和奥曲肽治疗肝硬化相关血流动力学并发症。
Ann Pharmacother. 2009 Apr;43(4):692-9. doi: 10.1345/aph.1L373. Epub 2009 Mar 18.
4
Comparison of the effect of midodrine versus octreotide on hemodynamic status in cirrhotic patients with ascites.米多君与奥曲肽对肝硬化腹水患者血流动力学状态影响的比较。
J Res Med Sci. 2011 Jan;16(1):87-93.
5
Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.口服α-肾上腺素能激动剂米多君对肝硬化腹水患者肾血流动力学和肾功能的急性影响。
Hepatology. 1998 Oct;28(4):937-43. doi: 10.1002/hep.510280407.
6
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.米多君、奥曲肽、白蛋白及经颈静脉肝内门体分流术用于特定肝硬化合并1型肝肾综合征患者
Hepatology. 2004 Jul;40(1):55-64. doi: 10.1002/hep.20262.
7
The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.奥曲肽和米多君联合治疗并不优于白蛋白预防大量腹腔穿刺放液后腹水复发。
Clin Gastroenterol Hepatol. 2012 Oct;10(10):1169-75. doi: 10.1016/j.cgh.2012.06.027. Epub 2012 Jul 16.
8
Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.米多君与奥曲肽联合治疗对一名患有大量肝性胸腔积液和轻度腹水的肝硬化患者的血流动力学及肾脏钠处理的有益作用。
Nephrol Dial Transplant. 2005 Nov;20(11):2583. doi: 10.1093/ndt/gfi055. Epub 2005 Aug 16.
9
The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study.米多君、长效奥曲肽和白蛋白治疗1个月对难治性腹水的影响：一项初步研究。
Liver Int. 2009 Feb;29(2):169-74. doi: 10.1111/j.1478-3231.2008.01778.x. Epub 2008 May 19.
10
Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis.米多君对肝硬化腹水患者的影响：系统评价与荟萃分析。
J Dig Dis. 2016 Jan;17(1):11-9. doi: 10.1111/1751-2980.12304.
本文引用的文献
1
Comparison of the effect of midodrine versus octreotide on hemodynamic status in cirrhotic patients with ascites.米多君与奥曲肽对肝硬化腹水患者血流动力学状态影响的比较。
J Res Med Sci. 2011 Jan;16(1):87-93.
2
Midodrine and furosemide-induced natriuresis in cirrhotics with ascites.
Aliment Pharmacol Ther. 2011 Feb;33(3):415-6. doi: 10.1111/j.1365-2036.2010.04536.x.
3
Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.米多君对伴有和不伴有腹水的非氮质血症肝硬化患者进行为期7天治疗的效果。
J Hepatol. 2007 Feb;46(2):213-21. doi: 10.1016/j.jhep.2006.09.012. Epub 2006 Nov 10.
4
The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.奥曲肽、利尿剂或两者联合治疗对非氮质血症肝硬化腹水患者门静脉血流动力学的影响。
J Clin Gastroenterol. 2006 Apr;40(4):342-6. doi: 10.1097/01.mcg.0000210101.74618.61.
5
Octreotide in the treatment of refractory ascites of cirrhosis.奥曲肽治疗肝硬化难治性腹水
Scand J Gastroenterol. 2006 Jan;41(1):118-21. doi: 10.1080/00365520510024043.
6
Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.利尿剂、奥曲肽或两者联合治疗对非氮质血症肝硬化腹水患者的肾脏影响。
Nephrol Dial Transplant. 2005 Aug;20(8):1623-9. doi: 10.1093/ndt/gfh871. Epub 2005 May 10.
7
The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.奥曲肽与奥曲肽联合米多君长期治疗对非氮质血症性肝硬化腹水患者全身血流动力学、肾血流动力学及肾功能的影响。
Am J Gastroenterol. 2005 Apr;100(4):879-85. doi: 10.1111/j.1572-0241.2005.40899.x.
8
Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.皮下注射奥曲肽对肝硬化腹水患者内源性血管活性系统及肾功能的影响。
Dig Dis Sci. 1998 Oct;43(10):2184-9. doi: 10.1023/a:1026698001921.
9
Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats.长期奥曲肽治疗可预防门静脉高压大鼠的血管反应性降低。
Hepatology. 1996 May;23(5):1218-23. doi: 10.1002/hep.510230541.
10
Effect of a new somatostatin analogue SMS 201-995 (Sandostatin) on the renin-aldosterone axis.
Clin Endocrinol (Oxf). 1988 Jan;28(1):25-32. doi: 10.1111/j.1365-2265.1988.tb01199.x.
Zotero 插件